Dermatological aspects of Lyme borreliosis;Aspects dermatologiques au cours de la maladie de Lyme

Medecine et Maladies Infectieuses

Volumn 37, Issue 7-8, 2007, Pages 540-547

  Lipsker, D ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b GEBLY Groupe d'étude de la borréliose de Lyme   (France)

Author keywords

Acrodermatitis chronica atrophicans; Borrelial lymphocytoma; Erythema migrans; Lyme borreliosis; Morphea

Indexed keywords

ACRODERMATITIS; ARTHRITIS; ARTICLE; B CELL LYMPHOMA; BORRELIA BURGDORFERI; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; EPIDERMOLYSIS; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; LYME DISEASE; MORPHEA; NEUROLOGIC DISEASE; NORTH AMERICA; PERIARTICULAR JOINT DISEASE; PERIPHERAL VEIN; SKIN DISEASE; SKIN INFLAMMATION; SKIN MANIFESTATION; TICK BORNE DISEASE; ZOONOSIS; CLASSIFICATION; EUROPE; MICROBIOLOGY;

BORRELIA BURGDORFERI GROUP; ERYTHEMA CHRONICUM MIGRANS; EUROPE; HUMANS; LYME DISEASE; NORTH AMERICA; SKIN DISEASES;

EID: 34548462601     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2006.01.013     Document Type: Article

References (69)

1. Afzelius A. Verhandlungen des dermatologischen Gesellschaft zu Stockholm. Arch. Dermatol. Syph. 101 (1910) 405-406
2. Lipschütz B. Uber eine seltene Erythemform (erythema chronicum migrans). Arch Dermatol Syph 118 (1913) 349-356
3. Scrimenti R.J. Erythema chronicum migrans. Arch. Dermatol. 102 (1970) 104-105
4. Herxheimer K., and Hartman K. Über acrodermatitis chronica atrophicans. Arch Dermatol (Berlin) 61 (1902) 57-76
5. Marchionini A. À propos de l'étiologie de l'acrodermatite chronique atrophiante de Pick-Herxmeimer. Ann. Dermatol. Venereol. 83 (1956) 601-611
6. Bafverstedt B. Über lymphadenosis benigne cutis, eine klinische une pathologisch-anatomische Studie (1943), PA Nordstedt und Sonner, Stockholm
7. Garin C., and Bujadoux D. Paralysie par les tiques. J. Med. Lyon 77 (1922) 765-767
8. Steere A.C., Boderick T.F., and Malawista S.E. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick-vector. Am. J. Epidemiol. 108 (1978) 312-321
9. Steere A.C., Malawista S.E., Snydman D.R., Shope R.E., Andiman W.A., Ross M.R., et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 20 (1977) 7-17
10. Burgdorfer W., Barbour A.G., Hayes S.F., Benach J.L., Grunwaldt E., and Davis J.P. Lyme disease: a tick-borne spirochetosis?. Science 216 (1982) 1317-1319
11. Welsch J., Pretzman C., Postic D., Saint Girons I., Baranton G., and McClelland M. Genomic fingerprints by arbitrarly primed polymerase chain reaction resolves Borrelia burgdorferi into three distinct phyletic groups. Int. J. Syst. Bacteriol. 42 (1992) 370-377
12. Berglund J., Eitrem R., Ornstein K., Lindberg A., Ringner A., Elmrud H., et al. An epidemiologic study of Lyme disease in southern Sweden. N. Engl. J. Med. 333 (1995) 1319-1324
13. Letrilliart L., Ragon B., Hanslik T., and Flahault A. Lyme disease in France: a primary care-based propspective study. Epidemiol. Infect. 133 (2005) 935-942
14. Stanek G., and Strle F. Lyme borreliosis. Lancet 362 (2003) 1639-1647
15. Steere A.C. Lyme disease. N. Engl. J. Med. 345 (2001) 115-125
16. Wormser G.P. Early Lyme diseases. N. Engl. J. Med. 354 (2006) 2794-2801
17. Lipsker D., Antoni-Bach N., Hansmann Y., and Jaulhac B. Long term prognosis of patients treated for erythema migrans in France. Br. J. Dermatol. 146 (2002) 872-876
18. Asbrink E., and Olsson I. Clinical manifestations of erythema migrans Afzelius in 161 patients. Acta Derm Venereol (Stockh) 65 (1985) 43-52
19. Aberer E., Kahofer P., Binder B., Kinaciyan T., Scjauperl H., and Berghold A. Comparison of a two- or three-week regimen and a review of treatment of erythema migrans with phenoxymethylpenicillin. Dermatology 212 (2006) 160-167
20. Strle F., Nadelman R.B., Cimperman J., Nowakowski J., Picken R.N., Schwartz I., et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York state and by Borrelia afzelii in Slovenia. Ann. Intern. Med. 130 (1999) 32-36
21. Oksi J., Hietarinta M., and Viljanen M.K. Erythema migrans-influence of posture. Case report. APMIS 108 (2000) 649-651
22. Rahn D.W., and Malawista S.E. Lyme disease: recommendations for diagnosis and treatment. Ann. Intern. Med. 114 (1991) 472-481
23. Stanek G., O'Connell S., Cimmino M., Aberer E., Kristoferitsch W., Granström M., et al. European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien. Klin. Wochenschr. 108 (1996) 741
24. Weber K., and Wilske B. Mini erythema migrans- a sign of early Lyme borreliosis. Dermatology 212 (2006) 113-116
25. Gerber M.A., Shapiro E.D., Burke G.S., et al. Lyme disease in children in southeastern Connecticut. N. Engl. J. Med. 335 (1996) 1270-1274
26. Koning J.D., Bosma R.B., and Hoogkamp-Korstanje J.A.A. Demonstration of Spirochaetes in patients with Lyme disease with a modified silver stain. J. Med. Microbiol. 23 (1987) 261-267
27. Schwartz I., Wormser G.P., Schwartz J.J., Cooper D., Weissensee P., Gazumyan A., et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J. Clin. Microbiol. 30 (1992) 3082-3088
28. Antoni-Bach N., Jaulhac B., Hansmann Y., Limbach F., and Lipsker D. Espèces de Borrelia responsable d'érythème migrant en Alsace. Ann. Dermatol. Venereol. 129 (2002) 15-18
29. Berger B.W., Johson R.C., Kodner C., and Coleman L. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J. Clin. Microbiol. 30 (1992) 359-361
30. Strle F., Nelson J.A., Ruzic-Sabljic E., Cimperman J., Maraspin V., Lotric-Furlan S., et al. European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans. Clin. Infect. Dis. 23 (1996) 61-65
31. Aberer E., Kersten A., Klade H., Poitschek C., and Jurecka W. Heterogeneity of Borrelia burgdorferi in the skin. Am. J. Dermatopathol. 18 (1996) 571-579
32. Berger B.W., Johnson R.C., Kodner C., and Coleman L. Cultivation of Borrelia burgdorferi from the blood of two patients with erythema migrans lesions lacking extracutaneous signs and symptoms of Lyme disease. J. Am. Acad. Dermatol. 30 (1994) 48-51
33. Picken R.N., Strle F., Ruzic-Sabljic E., Maraspin V., Lotric-Furlan S., Cimperman J., et al. Molecular subtyping of Borrelia burgdorferi sensu lato isolates from five patients with solitary lymphocytoma. J. Invest. Dermatol. 108 (1997) 92-97
34. Grosshans E., Meyer M., Capesius C., and Stoeckel E. Les infiltrations lymphocytaires aréolomamelonnaires. Le lymphocytome cutané bénin de l'aréole mammaire. Ann. Dermatol. Venereol. 107 (1980) 153-161
35. Colli C., Leinweber B., Mülleger R., Chott A., Kerl H., and Cerroni L. Borrelia-burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J. Cutan. Pathol. 31 (2004) 232-240
36. Strle F., Pleterski-Rigler D., Stanek G., Pejovnik-Pustinek A., Ruzic E., and Cimperman J. Solitary borrelial lymphocytoma: report of 36 cases. Infection 20 (1992) 201-206
37. Grosshans E. La maladie de Pick Herxheimer. Ann. Dermatol. Venereol. 129 (2002) 1063-1066
38. Brehmer-Andersson E., Hovmark A., and Asbrink E. Acrodermatitis chronica atrophicans: histopathologic findings and clinical correlations in 111 cases. Acta Derm Venereol (Stockh) 78 (1998) 207-213
39. Picken R.N., Strle F., Picken M.M., Ruzic-Sabljic E., Maraspin V., Lotric-Furlan S., et al. Identification of three species of Borrelia burgdorferi sensu lato (Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions. J. Invest. Dermatol. 110 (1998) 211-214
40. de Koning J., Tazelaar D.J., Hoogkamp-Korstanje J.A., and Elema J.D. Acrodermatitis chronica atrophicans: a light and electron microscopic study. J. Cutan. Pathol. 22 (1995) 23-32
41. Buechner S.A., Rufli T., and Erb P. Acrodermatitis chronica atrophicans: a chronic T-cell-mediated immune reaction against Borrelia burgdorferi?. J. Am. Acad. Dermatol. 28 (1993) 399-405
42. Abele D.C., and Anders K.H. The many faces and phases of borreliosis. J. Am. Acad. Dermatol. 23 (1990) 401-410
43. Malane M.S., Grant-Kels J.M., Feder H.M., and Luger S.W. Diagnosis of Lyme diease based on dermatologic manifestations. Ann. Intern. Med. 114 (1991) 490-498
44. Halkier-Sorensen L., Kragballe K., and Hansen K. Antibodies to the Borrelia burgdorferi flagellum in patients with scleroderma, granuloma annulare and porphyria cutanea tarda. Acta Derm. Venereol. (Stockh) 69 S (1989) 116-119
45. Stanek G., Konrad K., Jung M., and Ehringer H. Shulman syndrome, a scleroderma subtype caused by Borrelia burgdorferi?. Lancet 1 (1987) 1490
46. Abele D.C., Bedinfield R.B., Chandler F.W., and Given K.S. Progressive facial hemiatrophy (Parry-Romberg syndrome) and borreliosis. J. Am. Acad. Dermatol. 22 (1990) 531-533
47. Rabb D.C., Lesher Jr. J.L., and Chandler F.W. Polymerase chain reaction confirmation of Borrelia burgdorferi in benign lymphocytic infiltrate of the dermis. J. Am. Acad. Dermatol. 26 (1992) 267-268
48. Horowitz H.W., Sanghera K., Goldberg N., Pechman D., Kamer R., Duray P., et al. Dermatomyositis associated with Lyme disease: case report and review of Lyme myositis. Clin. Infect. Dis. 18 (1994) 166-171
49. Arnett F.C. The Lyme spirochete: another cause of Reiter's syndrome?. Arthritis Rheum. 32 (1989) 1182-1184
50. Hoesly J.M., Mertz L.E., and Winkelmann R.K. Localized scleroderma (morphea) and antibody to Borrelia burgdorferi. J. Am. Acad. Dermatol. 17 (1987) 455-458
51. Vaillant L., and Goudeau A. Localized scleroderma is not a Borrelia burgdorferi infection in France (letter). Dermatology 184 (1992) 286
52. Akimoto S., Ishikawa O., and Miyachi Y. The absence of antibodies against Borrelia burgdorferi in the sera of Japanese patients with localized morphea. J. Rheumatol. 23 (1996) 573-574
53. Dillon W.I., Saed G.M., and Fivenson D.P. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J. Am. Acad. Dermatol. 33 (1995) 617-620
54. Fan W., Leonardi C.L., and Penneys N.S. Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea). J. Am. Acad. Dermatol. 33 (1995) 682-684
55. Fujiwara H., Fujiwara K., Hashimoto K., Mehregan A.H., Schaumburg-Lever G., Lange R., et al. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch. Dermatol. 133 (1997) 41-44
56. Meis J.F., Koopman R., van Bergen B., Pool G., and Melchers W. No evidence for relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea). Arch. Dermatol. 129 (1993) 386-387
57. Ranki A., Aavik E., Peterson P., Schauman K., and Nurmilaakso P. Successfull amplification of DNA specific for Finish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions. J. Invest. Dermatol. 102 (1994) 339-345
58. Schempp C., Bocklage H., Lange R., Kölmel H.W., Orfanos C.E., and Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J. Invest. Dermatol. 100 (1993) 717-720
59. Wienecke R., Schlüpen E.M., Zöling N., Neubert U., Meurer M., and Volkenandt M. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J. Invest. Dermatol. 104 (1995) 23-26
60. Goodlad J.R., Davidson M.M., Gordon P., Billington R., and Ho-Yen D.O. Morphoe and Borrelia burgdorferi: results from the Scittish Highlands in the context of the world literature. J Clin Pathol: Mol Pathol 55 (2002) 374-378
61. Kaya G., Berset M., Prins C., Chavaz P., and Saurat J.H. Chronic borreliosis presenting with morphea- and lichen sclerosus et atrophicus-like cutaneous lesions. A case report. Dermatology 202 (2001) 373-375
62. Weide B., Schittek B., Klycz T., Schüz K., Rassner B., Wilske B., et al. Morphea is neither associated with eatures of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br. J. Dermatol. 143 (2000) 780-785
63. Ozkan S., Atabey N., Fetil E., Erkizan V., and Gunes A.T. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int. J. Dermatol. 39 (2000) 278-283
64. Alonso-Llamazares J., Persing D.H., Anda P., Gibson L.E., Rutledge B.J., and Iglesias L. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review. Acta Derm. Venereol. 77 (1997) 299-304
65. Moreno C., Kutzner H., Palmedo G., Goerttler E., Carrasco L., and Requena L. Interstitial ganlomatous dermatitis with histiocytic pseudorosettes: a new histopathologic pattern in cutaneous borreliosis. Detection of Borrelia burgdorferi DNA sequences by a highly sensitive PCR-RLISA. J. Am. Acad. Dermatol. 48 (2003) 376-384
66. Bataille A.C., Lipsker D., Walther S., Cribier B., and Grosshans E. Lymphome cutané T non épidermotrope sur acrodermatite chronique atrophiante. Ann. Dermatol. Venereol. 124 S (1997) 140
67. Cerroni L., Zöchling N., Pütz B., and Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J. Cutan. Pathol. 24 (1997) 457-461
68. Garbe C., Stein H., Gollnick H., Taud W., and Orfanos C.E. Kutanes B-Zell-Lymphom bei chronischer Borrelia-Burgdorferi-Infektion. Bericht über zwei Fälle und Literaturübersicht. Hautarzt 39 (1988) 717-726
69. Kütting B., Bonsmann G., Metze D., Luger T.A., and Cerroni L. Borrelia burgdorferi-associated primary cutaneous B cell lymphoma : complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J. Am. Acad. Dermatol. 36 (1997) 311-314